(Q36849802)

16 August 2017

Revaccination of non- and low- responders after a standard three dose hepatitis B vaccine schedule (English)

1 reference

16 August 2017

1 reference

0 references

1 reference

Ke Han

1

1 reference

16 August 2017

Xiaoping Shao

2

1 reference

16 August 2017

Huizhen Zheng

3

1 reference

16 August 2017

Chenggang Wu

4

1 reference

16 August 2017

Jianqiong Zhu

5

1 reference

16 August 2017

Xiaoli Zheng

6

1 reference

16 August 2017

Yonghui Zhang

7

1 reference

16 August 2017

language of work or name

1 reference

21 August 2012

1 reference

Human Vaccines & Immunotherapeutics

16 August 2017

1 reference

16 August 2017

8

1 reference

16 August 2017

12

1 reference

16 August 2017

1845-1849

1 reference

Safety and immunogenicity of hepatitis B vaccine administered into ventrogluteal vs. anterolateral thigh sites in infants: a randomised controlled trial.

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Prevention and control of hepatitis B in China

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Hepatitis B vaccination in preterm infants

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Large surface proteins of hepatitis B virus containing the pre-s sequence

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Immune response to hepatitis B virus vaccine in 1-year-old preterm and term infants

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Hepatitis B vaccination. Non-responders must be detected ...

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Hepatitis B Immune Globulin as a Prophylactic Measure for Spouses Exposed to Acute Type B Hepatitis

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Intradermal recombinant hepatitis B vaccination (IDRV) for non-responsive healthcare workers (HCWs).

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Antibody titer in Iranian children 6 years after hepatitis B vaccine administration

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Comparative immunogenicity of hepatitis B vaccine administered into the ventrogluteal area and anterolateral thigh in infants.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Revaccination against hepatitis B virus of non-responding and low-responding infants immunised at birth. A parallel evaluation of rubella and tetanus vaccine

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Immunogenicity of Hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life

5 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FHV.21818

The preterm infant's antibody response to a combined diphtheria, tetanus, acellular pertussis and hepatitis B vaccine

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Anti-HBV neonatal immunization with recombinant vaccine. Part I. Critical appraisal for a long-lived antibody course

20 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FHV.21818

Hepatitis B immunization in infants of hepatitis B surface antigen-negative mothers

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656074

Immunogenicity of hepatitis B vaccine in term and preterm infants

20 October 2018

1 reference

12 December 2020

Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age

1 reference

12 December 2020

Over a decade of experience with a yeast recombinant hepatitis B vaccine

1 reference

12 December 2020

Criteria for successful hepatitis B vaccination in adults: results of a case study

1 reference

12 December 2020

1 reference

12 December 2020

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

1 reference

12 December 2020

Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine

1 reference

12 December 2020

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

1 reference

12 December 2020

ELISA determination of IgG antibodies to pneumococcal capsular polysaccharides in a group of children

1 reference

12 December 2020

Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination

1 reference

12 December 2020

American Academy of Pediatrics Committee on Infectious Diseases: Universal hepatitis B immunization

1 reference

12 December 2020

A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates

1 reference

12 December 2020

What level of hepatitis B antibody is protective?

1 reference

12 December 2020

Identifiers

DOI

10.4161/HV.21818

1 reference

16 August 2017

1 reference

16 August 2017

1 reference